Cisplatin induced almost complete growth inhibition of HCC1937-derived (BRCA1-mutated) breast cancer xenografts, while BRCA1-reconsituted HCC1937 xenografted tumors showed only partial response to cisplatin treatment. Here, BRCA1 is linked to breast cancer.